Segui
Mark C Petrie
Mark C Petrie
Email verificata su glasgow.ac.uk
Titolo
Citata da
Citata da
Anno
Dapagliflozin in patients with heart failure and reduced ejection fraction
JJV McMurray, SD Solomon, SE Inzucchi, L Køber, MN Kosiborod, ...
New England Journal of Medicine 381 (21), 1995-2008, 2019
65072019
ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute …
Authors/Task Force Members, CW Hamm, JP Bassand, S Agewall, J Bax, ...
European heart journal 32 (23), 2999-3054, 2011
51342011
Coronary-artery bypass surgery in patients with left ventricular dysfunction
EJ Velazquez, KL Lee, MA Deja, A Jain, G Sopko, A Marchenko, IS Ali, ...
New England Journal of Medicine 364 (17), 1607-1616, 2011
14722011
Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials
SL Kristensen, R Rørth, PS Jhund, KF Docherty, N Sattar, D Preiss, ...
The lancet Diabetes & endocrinology 7 (10), 776-785, 2019
14282019
Current state of knowledge on aetiology, diagnosis, management, and therapy of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the …
K Sliwa, D Hilfiker-Kleiner, MC Petrie, A Mebazaa, B Pieske, E Buchmann, ...
European journal of heart failure 12 (8), 767-778, 2010
13282010
Coronary-artery bypass surgery in patients with ischemic cardiomyopathy
EJ Velazquez, KL Lee, RH Jones, HR Al-Khalidi, JA Hill, JA Panza, ...
New England Journal of Medicine 374 (16), 1511-1520, 2016
10462016
Heart failure and chronic obstructive pulmonary disease: diagnostic pitfalls and epidemiology
NM Hawkins, MC Petrie, PS Jhund, GW Chalmers, FG Dunn, ...
European journal of heart failure 11 (2), 130-139, 2009
8072009
Impact of diabetes on outcomes in patients with low and preserved ejection fraction heart failure: an analysis of the Candesartan in Heart failure: Assessment of Reduction in …
MR MacDonald, MC Petrie, F Varyani, J Östergren, EL Michelson, ...
European heart journal 29 (11), 1377-1385, 2008
7982008
Type 2 diabetes mellitus and heart failure: a position statement from the Heart Failure Association of the European Society of Cardiology
PM Seferović, MC Petrie, GS Filippatos, SD Anker, G Rosano, ...
European journal of heart failure 20 (5), 853-872, 2018
7182018
Randomised controlled trial of specialist nurse intervention in heart failure
L Blue, E Lang, JJV McMurray, AP Davie, TA McDonagh, DR Murdoch, ...
Bmj 323 (7315), 715-718, 2001
7172001
Clinical epidemiology of heart failure: public and private health burden.
JJ McMurray, MC Petrie, DR Murdoch, AP Davie
European heart journal 19, P9-16, 1998
6201998
Semaglutide in patients with heart failure with preserved ejection fraction and obesity
MN Kosiborod, SZ Abildstrøm, BA Borlaug, J Butler, S Rasmussen, ...
New England Journal of Medicine 389 (12), 1069-1084, 2023
5442023
Effect of dapagliflozin on worsening heart failure and cardiovascular death in patients with heart failure with and without diabetes
MC Petrie, S Verma, KF Docherty, SE Inzucchi, I Anand, J Bělohlávek, ...
Jama 323 (14), 1353-1368, 2020
5152020
Declining risk of sudden death in heart failure
L Shen, PS Jhund, MC Petrie, BL Claggett, S Barlera, JGF Cleland, ...
New England Journal of Medicine 377 (1), 41-51, 2017
5132017
Do patients with suspected heart failure and preserved left ventricular systolic function suffer from “diastolic heart failure” or from misdiagnosis? A prospective descriptive …
L Caruana, MC Petrie, AP Davie, JJV McMurray
Bmj 321 (7255), 215-218, 2000
4692000
Pathophysiology, diagnosis and management of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Study …
J Bauersachs, T König, P van der Meer, MC Petrie, D Hilfiker‐Kleiner, ...
European journal of heart failure 21 (7), 827-843, 2019
4072019
Effects of dapagliflozin on symptoms, function, and quality of life in patients with heart failure and reduced ejection fraction: results from the DAPA-HF trial
MN Kosiborod, PS Jhund, KF Docherty, M Diez, MC Petrie, S Verma, ...
Circulation 141 (2), 90-99, 2020
3832020
Percutaneous revascularization for ischemic left ventricular dysfunction
D Perera, T Clayton, PD O’Kane, JP Greenwood, R Weerackody, M Ryan, ...
New England Journal of Medicine 387 (15), 1351-1360, 2022
3702022
Effect of empagliflozin on left ventricular volumes in patients with type 2 diabetes, or prediabetes, and heart failure with reduced ejection fraction (SUGAR-DM-HF)
MMY Lee, KJM Brooksbank, K Wetherall, K Mangion, G Roditi, ...
Circulation 143 (6), 516-525, 2021
3702021
Radiofrequency ablation for persistent atrial fibrillation in patients with advanced heart failure and severe left ventricular systolic dysfunction: a randomised controlled trial
MR MacDonald, DT Connelly, NM Hawkins, T Steedman, J Payne, ...
Heart 97 (9), 740-747, 2011
3702011
Il sistema al momento non può eseguire l'operazione. Riprova più tardi.
Articoli 1–20